Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

CVS Health Corp DRC (CVS)

CBOE Canada
Currency in CAD
14.16
-0.29(-2.01%)
Closed

CVS Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa255,765267,908290,912321,629356,623
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+31.89%+4.75%+8.59%+10.56%+10.88%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa211,248219,660239,991267,965303,345
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa44,51748,24850,92153,66453,278
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+44.17%+8.38%+5.54%+5.39%-0.72%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa17.41%18.01%17.5%16.69%14.94%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa32,69934,58536,76437,92239,205
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+57%+5.77%+6.3%+3.15%+3.38%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa32,69934,58536,76437,92239,205
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa11,81813,66314,15715,74214,073
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+17.58%+15.61%+3.62%+11.2%-10.6%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa4.62%5.1%4.87%4.89%3.95%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-2,024-2,109-1,304-1,449-1,505
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-3.32%-4.2%+38.17%-11.12%-3.86%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-3,035-2,907-2,503-2,287-2,658
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,0117981,1998381,153
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-7-12-4-4-6
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa9,78711,54212,84914,28912,562
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa----2,533-349
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-79-1,440-391-5,803-
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa8,9979,77010,5375,83611,173
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+539.9%+8.59%+7.85%-44.61%+91.45%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa3.52%3.65%3.62%1.81%3.13%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa2,3662,5692,5481,5092,805
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa6,6317,1927,9894,3278,368
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa3-1312-16-24
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa6,6347,1798,0014,3118,344
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,216.84%+8.22%+11.45%-46.12%+93.55%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa2.59%2.68%2.75%1.34%2.34%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa5----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa6,6297,1888,0014,3118,344
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa5.15.496.073.296.49
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+991.04%+7.77%+10.47%-45.83%+97.62%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa5.085.476.023.266.47
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+988.36%+7.68%+10.05%-45.85%+98.47%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,3011,3091,3191,3121,285
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,3051,3141,3291,3231,290
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa2222.22.42
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa0%0%0%+10%+10%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa16,18918,10418,64319,96618,439
EBITDA Growth
aa.aaaa.aa